The largest database of trusted experimental protocols

4 protocols using 3 methyladenin 3 ma

1

Apoptosis and Autophagy Inhibitor Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pan Bcl-2 inhibitor (−)-gossypol (>98% purity) was acquired from Tocris (Bristol, United Kingdom). Autophagy inhibitors Bafilomycin A1 (BafA1), and 3-Methyladenin (3-MA) were obtained from Sigma-Aldrich (Taufkirchen, Germany). The pan-caspase inhibitor z-Val-Ala-DL-Asp(OMe)-fluoromethylketone (z-VAD) was purchased from Bachem (Weil am Rhein, Germany). The Mcl-1 sparing Bcl-2 inhibitor ABT-737 was from Santa Cruz Biotechnology (Heidelberg, Germany) and the inductor of apoptotic cell death staurosporine (STS) was from Alexis Biochemicals (by ENZO Life Sciences, Lörrach, Germany). Chemotherapeutic gemcitabine was from Fresenius-Kabi (Bad Homburg, Germany) and chemotherapeutic cisplatin from Teva (Ulm, Germany). Lysotracker Red DND-99 was obtained from Invitrogen (Karlsruhe, Germany). All other chemicals were used in analytic grade purity from Sigma-Aldrich.
+ Open protocol
+ Expand
2

Ferroptosis Mechanism of HepG2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HepG2 cell line was obtained from HonorGene (Changsha, China). Ferrostatin-1, MTT, 3-methyladenin (3-MA), chloroquine (CQ), RPMI-1640, and other chemicals were purchased from Sigma-Aldrich. 2-Pyridylhydrazone dithiocarbamate s-acetic acid (PdtaA) was prepared in our laboratory [27 (link)]. GPx4, xCT (SLC7A11), NDRG1, vimentin, and NCOA4 antibody were obtained from the Proteintech Group (Wuhan, China). Antibodies of E-cadherin and secondary antibodies (fluorescence-labeled for immunofluorescence) were purchased from Cell Signaling Technology (USA). Ferritin antibody for immunofluorescence was obtained from Santa Cruz Biotechnology (USA, Santa Cruz). NCOA4 antibody for immunofluorescence was purchased from Atlas Antibody (Sweden). Secondary antibodies for Western blotting were obtained from EarthOx, LLC (San Francisco, USA).
+ Open protocol
+ Expand
3

Ferroptosis Pathway Regulation in HepG2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HepG2 cell line was obtained from HonorGene; Changsha Aibiwei Biotechnology Co., Ltd. Ferrostatin-1, MTT, di-2-pyridylketone, 3-methyladenin (3-MA), RPMI-1640, and other chemicals were purchased from Sigma-Aldrich; Merck KGaA. GPx4, xCT (SLC7A11), vimentin, nuclear receptor coactivator-4 (NCOA4), and LC3 antibodies were obtained from ProteinTech Group, Inc. Antibodies against p53, caspase-8, GAPDH, Bax, and Bcl-2 were purchased from Wuhan Boster Biological Technology, Ltd. Antibodies targeting E-cadherin and secondary antibodies (fluorescence-labeled for immunofluorescence) were purchased from Cell Signaling Biotechnology, Inc. Ferritin antibody for immunofluorescence was obtained from Santa Cruz Biotechnology, Inc. NCOA4 antibody for immunofluorescence was purchased from Atlas Antibodies. Secondary antibodies for western blotting were obtained from EarthOx Life Sciences.
+ Open protocol
+ Expand
4

Ferroptosis Modulation in Hippocampal Neurons

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ferroptosis inducer erastin (Cat# HY-15763, Hvcultec, Beutelsbach, Germany), Fer-1 (ferroptosis inhibitor, Cat# ab146169, Abcam, Berlin, Germany), and 3-methyladenin (3-MA [autophagy inhibitor], Sigma, Taufkirchen, Germany) were dissolved in dimethyl sulfoxide (DMSO; Sigma). Deferoxamine (DFO, ferroptosis inhibitor, Sigma) was dissolved in deionized water. Cells were seeded in 96-well plates for viability assay, 24-well plates for immunofluorescence staining, and western blot assay. To assess the optimal concentration of erastin, hippocampal HT22 neurons were exposed to the drug at 0.3, 0.4, 0.5, 0.6, 0.7, and 0.8 µM for 12 hours.
Different concentrations of Fer-1 (10 and 20 µM) and DFO (100 and 200 µM) were applied to hippocampal HT22 neurons after 12 hours of erastin treatment (0 and 5 µM). The optimal experimental conditions occurred after incubation with 20 µM for Fer-1 and 100 µM for DFO. After 6, 12, and 24 hours, the subsequent analyses were conducted.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!